Sands Capital's position in Dexcom is currently worth $1.92 Billion. That's 5.33% of their entire equity portfolio (3rd largest holding). The investor owns 3.81% of the outstanding Dexcom stock. The first Dexcom trade was made in Q1 2020. Since then Sands Capital bought shares nine more times and sold shares on six occasions. The stake costed the investor $1.42 Billion, netting the investor a gain of 35% so far.
Brown Capital Management, an investment management company, released its “The Brown Capital Management Mid Company Fund” fourth quarter 2023 investor letter....
Insider Monkey, about 1 month agoHedge Fund Carlson Shrinks To One Office After Assets Fall 90% (Bloomberg) Hong Kong Investor Files Court Injunction On NEC’s JAE Stake Sale (The Business Ti...
Insider Monkey, 2 months ago… the period. Capital World Investors ’ holdings in DexCom were … funds and other institutional investors have also recently added … stock is owned by instit...
EIN News Investing, 6 months agoBrinker Capital Investments LLC trimmed its position in shares of DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 4.0% during the 4th quarter, HoldingsChannel rep...
The AM Reporter, about 1 year ago